Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Authors:
- Robert A. HodgsonRHRobert A. Hodgson
- Paul J. BedardPBPaul J. Bedard
- Geoffrey B. VartyGVGeoffrey B. Varty
- Tatiana M. KazdobaTKTatiana M. Kazdoba
- Therese Di PaoloTPTherese Di Paolo
- Michael E. GrzelakMGMichael E. Grzelak
- Annamarie J. PondAPAnnamarie J. Pond
- Abdallah HadjTaharAHAbdallah HadjTahar
- Nancy BelangerNBNancy Belanger
- Laurent GregoireLGLaurent Gregoire
- Aurelie DareADAurelie Dare
- Bernard R. NeustadtBNBernard R. Neustadt
- 1 October 2010
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 225 (2) , 384-390
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesiasBrain, 2004
- The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonismBehavioural Brain Research, 2004
- A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s diseaseExperimental Neurology, 2003
- Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PDNeurology, 2003
- Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's DiseaseJournal of Neuroscience, 2001
- Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsyNeuroReport, 2001
- Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatumJournal of Comparative Neurology, 2001
- Antiparkinsonian effect of a new selective adenosine A2Areceptor antagonist in MPTP-treated monkeysNeurology, 1999
- Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeysJournal of Neural Transmission, 1996
- Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingBrain Research, 1986